Pharmaceutical economics and policy : (Record no. 157606)

MARC details
000 -LEADER
fixed length control field 01824nam a2200409 i 4500
001 - CONTROL NUMBER
control field EDZ0001864520
003 - CONTROL NUMBER IDENTIFIER
control field StDuBDS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220902150110.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m||||||||d||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 180417s2018 nyua fob 001|0|eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780190623814 (ebook) :
Terms of availability No price
040 ## - CATALOGING SOURCE
Original cataloging agency StDuBDS
Language of cataloging eng
Transcribing agency StDuBDS
Description conventions rda
-- pn
050 #0 - LIBRARY OF CONGRESS CALL NUMBER
Classification number HD9666.5
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.4761510973
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schweitzer, Stuart O.,
Relator term author.
245 10 - TITLE STATEMENT
Title Pharmaceutical economics and policy :
Remainder of title perspectives, promises, and problems /
Statement of responsibility, etc Stuart O. Schweitzer and Z. John Lu.
250 ## - EDITION STATEMENT
Edition statement Third edition.
264 #1 -
-- New York, NY :
-- Oxford University Press,
-- 2018.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource :
Other physical details illustrations (black and white)
336 ## -
-- text
-- rdacontent
336 ## -
-- still image
-- rdacontent
337 ## -
-- computer
-- rdamedia
338 ## -
-- online resource
-- rdacarrier
500 ## - GENERAL NOTE
General note This edition previously issued in print: 2018.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 8# - SUMMARY, ETC.
Summary, etc Pharmaceuticals play a critical role in the raging debate over how best to advance and improve healthcare in the United States and the rest of the world. Using the analytical tools of economics, this text explores the conflicting priorities and aims of the biopharmaceutical industry.
521 ## - TARGET AUDIENCE NOTE
Target audience note Specialized.
588 ## -
-- Description based on online resource; title from home page (viewed on April 17, 2018).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical policy
Geographic subdivision United States.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lu, Z. John
Fuller form of name (Zhong John),
Relator term author.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version :
International Standard Book Number 9780190623784
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified Oxford scholarship online
Uniform Resource Identifier <a href="http://dx.doi.org/10.1093/oso/9780190623784.001.0001">http://dx.doi.org/10.1093/oso/9780190623784.001.0001</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks-SSH-OUP

No items available.

© 2024 IIIT-Delhi, library@iiitd.ac.in